120
Participants
Start Date
April 1, 2024
Primary Completion Date
March 1, 2025
Study Completion Date
December 1, 2025
2 clinical evaluations with 1 month in between
Patients will be evaluated twice with all evaluation methods selected by the international expert group (cfr. aim 1) showing sufficient reliability and feasibility in the patient group with LLL from aim 1
RECRUITING
University Hospitals of Leuven, Leuven
NOT_YET_RECRUITING
Nij Smellinghe Hospital, Drachten
Universitaire Ziekenhuizen KU Leuven
OTHER
Nij Smellinghe Hospital Drachten
UNKNOWN
KU Leuven
OTHER